This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov;89(11):1061-3.

doi: 10.1007/s00109-011-0810-y.

Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?

Jan Fritzsche¹, Philipp Stawowy

Affiliations

PMID: 21887504
DOI: 10.1007/s00109-011-0810-y

Comment

Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?

Jan Fritzsche et al. J Mol Med (Berl). 2011 Nov.

. 2011 Nov;89(11):1061-3.

doi: 10.1007/s00109-011-0810-y.

Authors

Jan Fritzsche¹, Philipp Stawowy

Affiliation

¹ Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

PMID: 21887504
DOI: 10.1007/s00109-011-0810-y

No abstract available

PubMed Disclaimer

Comment on

Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy.
Marchesi C, Essalmani R, Lemarié CA, Leibovitz E, Ebrahimian T, Paradis P, Seidah NG, Schiffrin EL, Prat A. Marchesi C, et al. J Mol Med (Berl). 2011 Nov;89(11):1103-11. doi: 10.1007/s00109-011-0776-9. Epub 2011 Jun 17. J Mol Med (Berl). 2011. PMID: 21681612

Similar articles

Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy.
Marchesi C, Essalmani R, Lemarié CA, Leibovitz E, Ebrahimian T, Paradis P, Seidah NG, Schiffrin EL, Prat A. Marchesi C, et al. J Mol Med (Berl). 2011 Nov;89(11):1103-11. doi: 10.1007/s00109-011-0776-9. Epub 2011 Jun 17. J Mol Med (Berl). 2011. PMID: 21681612
Implications of proprotein Convertase 5 (PC5) in the arterial restenotic process in a porcine model.
Veinot JP, Prichett-Pejic W, Picard P, Parks W, Schwartz R, Seidah NG, Chretien M. Veinot JP, et al. Cardiovasc Pathol. 2004 Sep-Oct;13(5):241-50. doi: 10.1016/j.carpath.2004.05.004. Cardiovasc Pathol. 2004. PMID: 15358338
Osteopontin as a novel substrate for the proprotein convertase 5/6 (PCSK5) in bone.
Hoac B, Susan-Resiga D, Essalmani R, Marcinkiweicz E, Seidah NG, McKee MD. Hoac B, et al. Bone. 2018 Feb;107:45-55. doi: 10.1016/j.bone.2017.11.002. Epub 2017 Nov 7. Bone. 2018. PMID: 29126984
Knock-out mouse models of proprotein convertases: unique functions or redundancy?
Creemers JW, Khatib AM. Creemers JW, et al. Front Biosci. 2008 May 1;13:4960-71. doi: 10.2741/3055. Front Biosci. 2008. PMID: 18508561 Review.
Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.
Stawowy P, Fleck E. Stawowy P, et al. J Mol Med (Berl). 2005 Nov;83(11):865-75. doi: 10.1007/s00109-005-0723-8. Epub 2005 Oct 22. J Mol Med (Berl). 2005. PMID: 16244876 Review.

See all similar articles

Cited by

Mouse Models of Human Proprotein Convertase Insufficiency.
Shakya M, Lindberg I. Shakya M, et al. Endocr Rev. 2021 May 25;42(3):259-294. doi: 10.1210/endrev/bnaa033. Endocr Rev. 2021. PMID: 33382413 Free PMC article. Review.

References

1. Can J Biochem. 1967 Jul;45(7):1163-74 - PubMed
1. Cardiovasc Res. 2005 Oct 1;68(1):136-43 - PubMed
1. Science. 1967 Aug 11;157(3789):697-700 - PubMed
1. Development. 1998 Dec;125(24):4863-76 - PubMed
1. Nat Rev Mol Cell Biol. 2002 Oct;3(10):753-66 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer